Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic Cancer
This study has been completed.
Sponsor:
Taiho Pharma USA, Inc.
Collaborator:
Quintiles
Information provided by:
Taiho Pharma USA, Inc.
ClinicalTrials.gov Identifier:
NCT00652054
First received: March 31, 2008
Last updated: March 17, 2011
Last verified: March 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | October 2007 |
| Primary Completion Date: | June 2007 (Final data collection date for primary outcome measure) |